Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis
Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis
批准号:
10595198
负责人:
Juhi Bagaitkar
金额:
$43.12万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-01-01 至 2027-12-31
关键词:
2019-nCoVAddressAgonistAnatomyAntiviral ResponseAntiviral resistanceBacterial InfectionsCellsChronicComplexDataDistantEpithelial CellsEpitheliumGene ExpressionGenesGingivaGoalsIRF1 geneImmuneImmune responseInfectionInflammationInflammatoryInflammatory ResponseInterferon ReceptorInterferon SuppressionInterferon Type IInterferon Type IIInterferonsLocalized DiseaseLocationMediatingMicrobeNF-kappa BNatureOncogenic VirusesOralOral cavityOral mucous membrane structureOropharyngealOutcomeParalysedPathogenicityPatientsPeptide HydrolasesPeriodontal DiseasesPeriodontitisPlayPorphyromonas gingivalisPredispositionProductionReactive Oxygen SpeciesRefractoryRegulationRoleSTAT1 geneSignal TransductionSiteSurfaceSystemic diseaseTestingTissuesViralVirulence FactorsVirusVirus Diseasesairway epitheliumantimicrobialantiviral drug developmentantiviral immunityautocrinecytokinedesensitizationdysbiosisgastrointestinalgenetic signaturegingipainin vivoinsightmouse modelneutrophilnoveloral cavity epitheliumoral tissueparacrinepromoterreceptorreceptor bindingrecruitreproductiverespiratoryrespiratory virusresponsetranscription factorviral resistance
中文摘要
摘要
这项建议解决了基于干扰素(干扰素)的口腔粘膜屏障抗病毒反应的性质,以及
影响其疗效的细菌因素。干扰素是一种抗病毒细胞因子,在限制所有方面都是至关重要的
病毒感染的可能性。我们发现,III型干扰素或干扰素lambdas(干扰素-λS)优先通过口头表达
上皮细胞和干扰素-λ相关信号在口腔给予强大的、广谱的抗病毒免疫
粘膜屏障。屏障部位的细菌定殖体有可能调节宿主对病毒的易感性
感染。与此相一致,我们发现牙龈卟啉单胞菌(Pg)与口腔
生物失调和牙周病,特别地和完全抑制了干扰素信号的所有方面
病毒激动剂。这项研究的总体目标是表征PG诱导的干扰素-λ抑制对血管内皮细胞的影响。
病毒清除和中性粒细胞功能,以及确定干扰素-λ抑制PG的相关性
殖民主义。我们的主要假设是,干扰素-λ优先在口腔粘膜屏障诱导,并赋予
抗病毒免疫保护,不会引起炎症。此外,我们假设PG使两者脱离接触
动态平衡和可诱导的干扰素-λ反应,从而增加宿主对口腔病毒感染的易感性和
慢性炎症,也是PG持续存在的原因。这些假设将在以下方面得到验证
明确的目标。目的1:研究PG介导的干扰素-λ信号抑制对病毒清除的影响
在活体内。目的2:确定干扰素-λ介导的中性粒细胞效应功能调节对组织的贡献
口腔病毒感染期间的损害和持续性炎症。目的:确定干扰素失活的作用
感染期间PG持续存在的信号转导。这项研究将提供基本的新奇信息,关于
PG在抑制口腔粘膜屏障抗微生物炎症反应中的作用。此外,一个
增加对口腔中提供抗病毒抵抗力的因素的了解具有非常重要的意义
包括SARS-Cov2在内的大量病毒可以感染口腔组织,引起局部和全身疾病。
英文摘要
ABSTRACT
This proposal addresses the nature of interferon (IFN)-based antiviral responses at the oral mucosal barrier, and
the bacterial factors that impact their efficacy. IFNs are antiviral cytokines that are critical in limiting all aspects
of viral infection. We found that Type III IFNs or IFN lambdas (IFN-λs) are preferentially expressed by oral
epithelial cells, and IFN-λ-associated signaling confers robust, broad-spectrum, antiviral immunity at the oral
mucosal barrier. Bacterial colonizers at barrier sites have the potential to modulate host susceptibility to viral
infection. Consistent with this, we found that Porphyromonas gingivalis (Pg), which is associated with oral
dysbiosis and periodontal disease, singularly and totally dampened all aspects of IFN signaling in response to
viral agonists. The overall goal of this study is to characterize the effect of Pg-induced IFN-λ suppression on
viral clearance and neutrophil function, as well as determine the relevance of IFN-λ suppression for Pg
colonization. Our main hypothesis is that IFN-λ is preferentially induced at the oral mucosal barrier and confers
antiviral immune protection without inducing inflammation. Further, we hypothesize that Pg disengages both
homeostatic and inducible IFN-λ responses, thereby enhancing host susceptibility to oral viral infection and to
chronic inflammation, as well as contributing to Pg persistence. These hypotheses will be tested in the following
specific aims. Aim 1: Characterize the impact of Pg-mediated suppression of IFN-λ signaling on viral clearance
in vivo. Aim 2: Determine the contribution of IFN-λ mediated regulation of neutrophil effector functions to tissue
damage and persistent inflammation during oral viral infections. Aim3: Determine the role of inactivation of IFN
signaling in Pg persistence during infection. This study will provide fundamental novel information on the role of
Pg in the suppression of anti-microbial inflammatory responses at the oral mucosal barrier. Additionally, an
increased understanding of the factors that provide antiviral resistance in the oral cavity is highly significant as a
large number of viruses, including SARS-Cov2, can infect oral tissues and cause local and systemic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A T.fosythia-derived protease inhibitor in periodontal health and disease
-
批准号:10447716
-
项目类别:
-
资助金额:$52.85万
-
财政年份:2021
-
负责人:Juhi Bagaitkar
-
依托单位:
A T.fosythia-derived protease inhibitor in periodontal health and disease
-
批准号:10279103
-
项目类别:
-
资助金额:$54.69万
-
财政年份:2021
-
负责人:Juhi Bagaitkar
-
依托单位:
A T.fosythia-derived protease inhibitor in periodontal health and disease
-
批准号:10673635
-
项目类别:
-
资助金额:$53.38万
-
财政年份:2021
-
负责人:Juhi Bagaitkar
-
依托单位:
Redox Regulation of Gingival Inflammation
-
批准号:9885641
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Juhi Bagaitkar
-
依托单位:
Redox Regulation of Gingival Inflammation
-
批准号:10579090
-
项目类别:
-
资助金额:$36.73万
-
财政年份:2019
-
负责人:Juhi Bagaitkar
-
依托单位:
Redox Regulation of Gingival Inflammation
-
批准号:10530608
-
项目类别:
-
资助金额:$45.73万
-
财政年份:2019
-
负责人:Juhi Bagaitkar
-
依托单位:
Redox Regulation of Gingival Inflammation
-
批准号:10308384
-
项目类别:
-
资助金额:$9.05万
-
财政年份:2019
-
负责人:Juhi Bagaitkar
-
依托单位:
海外基金